You have 9 free searches left this month | for more free features.

CLAG-M

Showing 1 - 25 of 1,786

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 18, 2022

Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

Not yet recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Navitoclax Dose Level -1
  • +10 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023

Acute Myeloid Leukemia Trial in Poland, United States (A arm (DA-90), B arm (DAC), A arm (CLAG-M))

Recruiting
  • Acute Myeloid Leukemia
  • A arm (DA-90)
  • +3 more
  • New York, New York
  • +9 more
Sep 30, 2021

Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Gilteritinib 40 MG Oral Tablet
  • +4 more
  • Lexington, Kentucky
    University of Kentucky
Oct 27, 2022

Acute Lymphoblastic Leukemia Trial in Suzhou (Cladribine, Fludarabine)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Oct 12, 2022

Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

Recruiting
  • Leukemia, Monocytic, Acute
  • Pediatric AML
  • Foshan, Guangdong, China
  • +8 more
Mar 28, 2022

Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • Best-Available Therapy(BAT) Regimen
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 10, 2023

Leukemia, Myeloid, Acute Trial in United States (DFP-10917, Cytarabine, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +38 more
Dec 25, 2021

AML Trial in Guanzhou (CLAG)

Not yet recruiting
  • AML
  • CLAG
  • Guanzhou, Guangdong, China
  • +1 more
May 16, 2023

Positive Rate of M Protein Based onHighly Sensitive Serum M

Recruiting
  • Multiple Myeloma
  • M Protein
    • Guangzhou, Guangdong, China
      Zhujiang Hospital of Southern Medical University
    Oct 9, 2023

    Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])

    Completed
    • Influenza
    • +4 more
    • Influenza vaccine [inactivated]
    • Kol'tsovo, Novosibirsk Region, Russian Federation
    • +4 more
    May 11, 2023

    Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Duarte, Hackensack, Houston (SIRPant-M, External-beam

    Not yet recruiting
    • Refractory Non-Hodgkin Lymphoma
    • Relapsed Non-Hodgkin Lymphoma
    • SIRPant-M
    • External-beam radiotherapy (XRT)
    • Duarte, California
    • +2 more
    Jul 21, 2023

    Post Operative Pain, Laparoscopic Surgery, Pediatrics Trial in Ankara (M-TAPA Block, Local anesthetic infltration to port sites)

    Enrolling by invitation
    • Post Operative Pain
    • +4 more
    • M-TAPA Block
    • Local anesthetic infltration to port sites
    • Ankara, Kecioren, Turkey
      Gulhane Training and Research Hospital
    Sep 8, 2023

    COVID-19 Trial in United States (NVX-CoV2373 (5µg), NVX-CoV2601 (5µg), NVX-CoV2601(5µg))

    Not yet recruiting
    • COVID-19
    • NVX-CoV2373 (5μg)
    • +6 more
    • Birmingham, Alabama
    • +47 more
    Jul 2, 2023

    Malassezia Species Isolated From Malassezia Associated Skin

    Not yet recruiting
    • Malassezia Infection
    • culture and antifungal sensitivity and molecular detection
    • Sohag, Egypt
      Sohag University Hospital
    Jul 25, 2022

    Perinatal Depression Trial (Center M, Treatment as Usual)

    Not yet recruiting
    • Perinatal Depression
    • Center M
    • Treatment as Usual
    • (no location specified)
    Aug 14, 2023

    Analgesic Efficacy of M-TAPA Block Accomplished Prior to Surgery in Patients Undergoing Laparoscopic Gynecological Surgeries

    Completed
    • Analgesic Efficacy of M-TAPA Block Accomplished Prior to Surgery in Patients Undergoing Laparoscopic Gynecological Surgeries
    • Alexandria, Egypt
      Alexandria University Faculty of Medicin
    Sep 9, 2023

    Children, Only Trial in Yogyakarta (Formula milk with triple Bifidobacterium probiotic strain, Formula milk)

    Active, not recruiting
    • Children, Only
    • Formula milk with triple Bifidobacterium probiotic strain
    • Formula milk
    • Yogyakarta, Special Region Of Yogyakarta, Indonesia
    • +9 more
    Sep 12, 2023

    Post Operative Pain Trial in Sivas (modified thoracoabdominal nerve block through perichondrial approach)

    Completed
    • Post Operative Pain
    • modified thoracoabdominal nerve block through perichondrial approach
    • Sivas, Turkey
      Sivas Cumhuriyet University
    May 26, 2023

    Establish Referenc Range of Antiphospholipid Antibody in Healthy

    Not yet recruiting
    • Focus Health Pregancy Women
    • Draw blood
    • (no location specified)
    May 20, 2023

    Stroke Trial in Istanbul (Downhill walking, Walking on flat ground)

    Not yet recruiting
    • Stroke
    • Downhill walking
    • Walking on flat ground
    • Istanbul, Turkey
      Mamara Üniversitesi Tıp Fakültesi
    Apr 26, 2023

    Altitude Hypoxia Trial in Bishkek (ACETAZOLAMIDE oral capsule, Placebo oral capsule)

    Active, not recruiting
    • Altitude Hypoxia
    • ACETAZOLAMIDE oral capsule
    • Placebo oral capsule
    • Bishkek, Kyrgyzstan
      National Center of Cardiology and Internal Medicine
    Nov 1, 2022

    Cesarean Section Trial in Bursa (Postoperative analgesia management)

    Recruiting
    • Cesarean Section
    • Postoperative analgesia management
    • Bursa, Turkey
    • +1 more
    Oct 13, 2023

    Monoclonal Gammopathies, Multiple Myeloma, M-protein Trial in Guangzhou (Observational studies, no intervention)

    Recruiting
    • Monoclonal Gammopathies
    • +2 more
    • Observational studies, no intervention
    • Guangzhou, Guangdong, China
      Zhujiang Hospital of Southern Medical University
    Jan 6, 2023

    Weight Loss, Bariatric Surgery Trial in Beverly Hills (Body Image/Self-Esteem Questionnaires)

    Recruiting
    • Weight Loss
    • Bariatric Surgery
    • Body Image/Self-Esteem Questionnaires
    • Beverly Hills, California
      Dr. Feiz and Associates
    Jan 24, 2023